Listen to the article
Kaiser Permanente affiliates have agreed to a $556 million settlement with the federal government to resolve allegations of Medicare Advantage fraud, marking one of the largest healthcare fraud settlements in recent years.
The Oakland-headquartered healthcare consortium was accused of violating the False Claims Act by systematically submitting invalid diagnosis codes for Medicare Advantage Plan enrollees to receive higher government payments. The settlement resolves claims brought by whistleblowers Ronda Osinek and Dr. James M. Taylor, both former Kaiser employees, who will receive $95 million of the recovery under the act’s provisions.
According to federal investigators, Kaiser engaged in a widespread scheme between 2009 and 2018 to artificially increase its Medicare reimbursements. The organization allegedly pressured physicians to add diagnoses after patient visits through “addenda” to medical records, often months or even more than a year after the actual appointments.
“Medicare Advantage is a vital program that must serve patients’ needs, not corporate profits,” said U.S. Attorney Craig H. Missakian for the Northern District of California. “Fraud on Medicare costs the public billions annually, so when a health plan knowingly submits false information to obtain higher payments, everyone — from beneficiaries to taxpayers — loses.”
The government claimed Kaiser developed mechanisms to mine patients’ past medical histories to identify potential diagnoses that had not been submitted to Medicare for risk adjustment. Queries were then sent to providers urging them to add these diagnoses to records, even when they had nothing to do with the patient visit in question—a direct violation of Centers for Medicare & Medicaid Services (CMS) requirements.
Kaiser reportedly established aggressive physician- and facility-specific goals for adding risk adjustment diagnoses, with financial incentives tied to meeting these targets. Underperforming physicians and facilities were singled out, with emphasis placed on how failure to add diagnoses cost money for Kaiser, its facilities, and the physicians themselves.
The settlement is particularly significant given Kaiser Permanente’s prominent position in the healthcare industry. As a non-profit integrated care provider, Kaiser operates the largest managed care organization in the United States with more than 9,470 staffed beds in California alone. Its closed network system serves members of the Kaiser Foundation Health Plan across multiple states including Hawaii, Washington, Oregon, Colorado, Maryland, Virginia, and Georgia.
The Kaiser Permanente affiliates included in the settlement are Kaiser Foundation Health Plan Inc.; Kaiser Foundation Health Plan of Colorado; The Permanente Medical Group Inc.; Southern California Permanente Medical Group; and Colorado Permanente Medical Group P.C.
The case highlights growing concerns about practices in the Medicare Advantage program, also known as Medicare Part C, which allows beneficiaries to opt out of traditional Medicare and enroll in private health plans offered by insurance companies. More than half of the nation’s Medicare beneficiaries are now enrolled in such plans.
Under the program’s risk adjustment system, CMS pays Medicare Advantage organizations a fixed monthly amount for each enrolled beneficiary, adjusted for risk factors affecting expected health expenditures. Plans receive higher payments for sicker beneficiaries expected to incur greater healthcare costs. These adjustments rely on diagnosis codes that must be supported by the medical record of a face-to-face patient visit.
“Today’s resolution sends the clear message that the United States holds healthcare providers and plans accountable when they knowingly submit or cause to be submitted false information to CMS to obtain inflated Medicare payments,” said Assistant Attorney General Brett A. Shumate of the Justice Department’s Civil Division.
The settlement resulted from coordinated efforts between the Justice Department’s Civil Division, Commercial Litigation Branch, Fraud Section, the U.S. Attorneys’ Offices for the Northern District of California and District of Colorado, with assistance from HHS Office of Inspector General, HHS Office of Audit Services, and the FBI.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.


11 Comments
This settlement highlights the importance of whistleblower programs in exposing healthcare fraud. I hope the $95 million awarded to the two former Kaiser employees encourages others to come forward when they witness unethical behavior.
Medicare Advantage fraud is a serious issue that costs taxpayers billions. I’m glad the government was able to recoup over $500 million in this case. Providers need to be held to high standards when it comes to accurately reporting patient diagnoses.
Absolutely. The financial incentives in Medicare Advantage can create perverse incentives if not properly monitored. This should serve as a wake-up call for the industry.
It’s good to see the government taking such a strong stance against Medicare Advantage fraud. Providers need to be held accountable for manipulating patient data to increase their reimbursements. Hopefully this sets a precedent for other cases.
Agreed. Rooting out fraud in government healthcare programs should be a top priority to protect taxpayer funds and ensure patients receive the care they need.
This is a significant healthcare fraud settlement involving Kaiser Permanente. It’s concerning that they allegedly pressured physicians to add diagnoses after patient visits to boost their Medicare Advantage reimbursements. Hopefully this serves as a warning to other providers against such unethical practices.
You’re right, the scale of this fraud is quite troubling. It’s good to see whistleblowers coming forward and the government taking action to hold Kaiser accountable.
I’m glad the whistleblowers in this case were able to recover a significant portion of the settlement amount. Their courage in coming forward helped uncover a major fraud scheme that impacted taxpayers and Medicare beneficiaries. More whistleblower protections are needed to incentivize this kind of action.
As a shareholder, I’m disappointed to see Kaiser Permanente engaging in this type of fraudulent behavior. It’s a breach of trust with their patients and the government. I hope this serves as a wake-up call for the organization to improve its compliance practices.
This is a sobering example of the potential for abuse in the Medicare Advantage program. While the program provides important coverage options, the financial incentives can clearly lead some providers down an unethical path. Stronger oversight and enforcement will be crucial going forward.
Well said. Medicare Advantage fraud undermines the entire program and erodes public trust. Rigorous auditing and meaningful penalties for bad actors are essential to protect the integrity of the system.